Evoke Pharma (EVOK) Tops Q4 EPS by 20c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.48), $0.20 better than the analyst estimate of ($0.68).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Exclusive: BitGo says institutional conversations are shifting to tokenization
• Benchmark Reiterates Buy Rating on NANO Nuclear Energy (NNE)